Helius Medical Technologies Stock Price, News & Analysis (OTCMKTS:HSDT)

Previous Close$2.33
Today's RangeN/A
52-Week Range$6.45 - $20.70
VolumeN/A
Average Volume8,036 shs
Market Capitalization$225.13 million
P/E Ratio-1.04
Dividend YieldN/A
Beta1.24

About Helius Medical Technologies (OTCMKTS:HSDT)

Helius Medical Technologies logoHelius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device. The device, when used in combination with physiotherapy, is designed to enhance the brain's ability to compensate for damage due to trauma or disease. The Company's PoNS device is designed to induce cranial nerve non-invasive neuromodulation through an increase in stimulation of the facial and trigeminal nerves, which innervate the tongue. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation. The PoNS device is an electrical pulse generator that delivers controlled electrical stimulation to the tongue.

Receive HSDT News and Ratings via Email

Sign-up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:HSDT
CUSIPN/A
Phone+1-215-8092018

Debt

Debt-to-Equity RatioN/A
Current Ratio0.26%
Quick Ratio0.26%

Price-To-Earnings

Trailing P/E Ratio-1.04347826086957
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($0.04) per share
Price / BookN/A

Profitability

Trailing EPS($2.08)
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on Assets-300.45%

Miscellaneous

EmployeesN/A
Outstanding Shares99,720,000

Helius Medical Technologies (OTCMKTS:HSDT) Frequently Asked Questions

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the OTCMKTS under the ticker symbol "HSDT."

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies Inc (OTCMKTS:HSDT) issued its earnings results on Friday, August, 14th. The company reported ($0.05) EPS for the quarter, beating the Zacks' consensus estimate of ($0.08) by $0.03. View Helius Medical Technologies' Earnings History.

Who are some of Helius Medical Technologies' key competitors?

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the folowing people:

  • Philippe Deschamps, President, Chief Executive Officer, Director (Age 54)
  • Joyce N. LaViscount, Chief Financial Officer, Chief Operating Officer (Age 54)
  • Brian Bapty, Vice President, Strategy and Business Development (Age 47)
  • Jonathan Sackier, Chief Medical Officer (Age 58)
  • Dane Andreeff, Director (Age 51)
  • Huaizheng Peng, Director (Age 54)
  • Mitch Eugene Tyler, Director (Age 63)
  • Thomas E. Griffin, Independent Director (Age 53)
  • Edward M. Straw, Independent Director (Age 77)

How do I buy Helius Medical Technologies stock?

Shares of Helius Medical Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is Helius Medical Technologies?

Helius Medical Technologies has a market capitalization of $225.13 million.

How can I contact Helius Medical Technologies?

Helius Medical Technologies' mailing address is 41 University Dr Ste 400, NEWTOWN, PA 18940-1873, United States. The company can be reached via phone at +1-215-8092018 or via email at [email protected]


MarketBeat Community Rating for Helius Medical Technologies (HSDT)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Helius Medical Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Helius Medical Technologies (OTCMKTS:HSDT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Helius Medical Technologies (OTCMKTS:HSDT) Consensus Price Target History

Price Target History for Helius Medical Technologies (OTCMKTS:HSDT)

Helius Medical Technologies (OTCMKTS:HSDT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/19/2016Greenridge GlobalUpgradeHold -> BuyView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Helius Medical Technologies (OTCMKTS:HSDT) Earnings History and Estimates Chart

Earnings by Quarter for Helius Medical Technologies (OTCMKTS:HSDT)

Helius Medical Technologies (OTCMKTS HSDT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2017Q3 2017($0.05)($0.07)ViewN/AView Earnings Details
8/14/2017Q2 2017($0.06)ViewN/AView Earnings Details
5/16/2017Q1 2017($0.06)ViewN/AView Earnings Details
11/14/2016Q3 2016($0.04)ViewN/AView Earnings Details
8/15/2016Q2 2016($0.04)ViewN/AView Earnings Details
6/27/2016Q1 2016($0.05)ViewN/AView Earnings Details
2/16/2016Q4 2015($0.04)($0.04)ViewN/AView Earnings Details
8/14/2015Q1 2016($0.08)($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Helius Medical Technologies (OTCMKTS:HSDT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Helius Medical Technologies (OTCMKTS:HSDT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Helius Medical Technologies (OTCMKTS HSDT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 39.70%
Insider Trades by Quarter for Helius Medical Technologies (OTCMKTS:HSDT)

Helius Medical Technologies (OTCMKTS HSDT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2017Dane AndreeffDirectorBuy255,101$1.96$499,997.96View SEC Filing  
12/22/2017Joyce N LaviscountCFOBuy79,082$1.96$155,000.72View SEC Filing  
12/22/2017Philippe DeschampsInsiderBuy127,551$1.96$249,999.96View SEC Filing  
11/17/2017Blane WalterDirectorBuy40,000$2.46$98,400.00View SEC Filing  
11/13/2017Dane AndreeffDirectorBuy167,000$2.58$430,860.00View SEC Filing  
9/10/2015Edward M StrawDirectorBuy12,500$0.80$10,000.0012,500View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Helius Medical Technologies (OTCMKTS HSDT) News Headlines

Source:
DateHeadline
Helius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® ResearchHelius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® Research
finance.yahoo.com - January 24 at 8:51 AM
Helius Medical Technologies Completes Reverse Split of its Class A Common StockHelius Medical Technologies Completes Reverse Split of its Class A Common Stock
finance.yahoo.com - January 23 at 9:05 AM
Joyce N. Laviscount Purchases 79,082 Shares of Helius Medical Technologies, Inc. (HSDT) StockJoyce N. Laviscount Purchases 79,082 Shares of Helius Medical Technologies, Inc. (HSDT) Stock
www.americanbankingnews.com - December 28 at 4:08 PM
Helius Medical Technologies, Inc. (HSDT) Insider Philippe Deschamps Buys 127,551 SharesHelius Medical Technologies, Inc. (HSDT) Insider Philippe Deschamps Buys 127,551 Shares
www.americanbankingnews.com - December 28 at 4:08 PM
Helius Medical Technologies, Inc. (HSDT) Director Dane Andreeff Acquires 255,101 SharesHelius Medical Technologies, Inc. (HSDT) Director Dane Andreeff Acquires 255,101 Shares
www.americanbankingnews.com - December 28 at 3:42 PM
Helius Medical Technologies Inc (HSDT) President and CEO Philippe Deschamps Bought $250,000 of ...Helius Medical Technologies Inc (HSDT) President and CEO Philippe Deschamps Bought $250,000 of ...
finance.yahoo.com - December 26 at 11:53 PM
Helius Medical Technologies Announces Closing of First Tranche of Private PlacementHelius Medical Technologies Announces Closing of First Tranche of Private Placement
finance.yahoo.com - December 23 at 4:29 AM
Helius Medical Technologies (HSDT) Downgraded by ValuEngine to "Sell"Helius Medical Technologies (HSDT) Downgraded by ValuEngine to "Sell"
www.americanbankingnews.com - December 3 at 11:22 AM
Blane Walter Acquires 40,000 Shares of Helius Medical Technologies, Inc. (HSDT) StockBlane Walter Acquires 40,000 Shares of Helius Medical Technologies, Inc. (HSDT) Stock
www.americanbankingnews.com - November 20 at 7:56 PM
Helius Medical Technologies, Inc. (HSDT) Director Buys $430,860.00 in StockHelius Medical Technologies, Inc. (HSDT) Director Buys $430,860.00 in Stock
www.americanbankingnews.com - November 13 at 5:14 PM
Helius Medical Technologies (HSDT) Reports On Results From Traumatic Brain Injury Clinical Trials -SlideshowHelius Medical Technologies (HSDT) Reports On Results From Traumatic Brain Injury Clinical Trials -Slideshow
seekingalpha.com - November 13 at 8:59 AM
Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)
finance.yahoo.com - November 11 at 9:51 AM
Helius Medical Technologies to Present at the Canaccord Genuity Medical Technologies and Diagnostics Conference on November 9, 2017Helius Medical Technologies to Present at the Canaccord Genuity Medical Technologies and Diagnostics Conference on November 9, 2017
feeds.benzinga.com - November 1 at 9:27 AM
Helius Medical Technologies Highlights Publication of Stroke Study From The Royal Melbourne Hospital in Australia Using Investigational PoNS™ DeviceHelius Medical Technologies Highlights Publication of Stroke Study From The Royal Melbourne Hospital in Australia Using Investigational PoNS™ Device
www.nasdaq.com - October 2 at 11:36 PM
Helius Medical Technologies Appoints Dane C. Andreeff to Board of DirectorsHelius Medical Technologies Appoints Dane C. Andreeff to Board of Directors
finance.yahoo.com - September 14 at 8:47 PM
Helius Medical Technologies Announces Extension of Collaborative Research and Development Agreement (CRADA) with US ArmyHelius Medical Technologies Announces Extension of Collaborative Research and Development Agreement (CRADA) with US Army
finance.yahoo.com - September 14 at 6:11 AM
Helius Medical Technologies Celebrates Grand Opening Ribbon Cutting Ceremony of New Corporate Facility in Newtown, PAHelius Medical Technologies Celebrates Grand Opening Ribbon Cutting Ceremony of New Corporate Facility in Newtown, PA
www.nasdaq.com - August 15 at 8:12 PM
Helius Medical Technologies Celebrates Grand Opening Ribbon Cutting Ceremony of New Corporate Facility in Newtown, PAHelius Medical Technologies Celebrates Grand Opening Ribbon Cutting Ceremony of New Corporate Facility in Newtown, PA
finance.yahoo.com - August 14 at 8:18 PM
Helius Medical Technologies Announces Newly Constituted Scientific Advisory BoardHelius Medical Technologies Announces Newly Constituted Scientific Advisory Board
finance.yahoo.com - July 31 at 7:03 PM
Helius Medical Technologies and the United States Army Medical Research and Materiel Command Announce Last Subject Enrolled In TBI Registrational Clinical TrialHelius Medical Technologies and the United States Army Medical Research and Materiel Command Announce Last Subject Enrolled In TBI Registrational Clinical Trial
finance.yahoo.com - July 14 at 2:54 AM
Helius Medical Technologies Announces Publication of Multiple Sclerosis Pilot Study Results in Multiple Sclerosis Journal: Experimental, Translational and ClinicalHelius Medical Technologies Announces Publication of Multiple Sclerosis Pilot Study Results in Multiple Sclerosis Journal: Experimental, Translational and Clinical
us.rd.yahoo.com - February 9 at 11:39 PM
Helius Medical launches CAD$10.8M stock offering; shares down 11%Helius Medical launches CAD$10.8M stock offering; shares down 11%
seekingalpha.com - February 9 at 6:38 PM
Helius Medical Technologies Inc. Announces CAD$10.8 Million Public Offering of Class A Common StockHelius Medical Technologies Inc. Announces CAD$10.8 Million Public Offering of Class A Common Stock
www.nasdaq.com - February 9 at 6:38 PM
HELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other EventsHELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events
biz.yahoo.com - February 8 at 6:25 PM
HELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Changes in Registrants Certifying Accountant, Amendments to ArHELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Amendments to Ar
biz.yahoo.com - January 10 at 6:40 PM
BRIEF-Helius Medical reached full enrollment in tactile communication and neurorehabilitation laboratory clinical trialBRIEF-Helius Medical reached full enrollment in tactile communication and neurorehabilitation laboratory clinical trial
www.reuters.com - December 5 at 11:04 AM
Helius Medical Technologies and HealthTech Connex Announce Preliminary Research Results Supporting Objective Physiologic Improvement in Cognitive Function with Investigational ...Helius Medical Technologies and HealthTech Connex Announce Preliminary Research Results Supporting Objective Physiologic Improvement in Cognitive Function with Investigational ...
www.businesswire.com - December 3 at 11:57 AM
Helius Medical Technologies and U.S. Army Extend Sole Source Contract for the PoNS Device Testing and DevelopmentHelius Medical Technologies and U.S. Army Extend Sole Source Contract for the PoNS Device Testing and Development
www.finanznachrichten.de - November 21 at 5:54 PM
HELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other EventsHELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
biz.yahoo.com - November 21 at 5:54 PM
(Photo: Business Wire)(Photo: Business Wire)
www.thestreet.com - November 10 at 11:16 PM
HELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 10-K/A, Annual ReportHELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 10-K/A, Annual Report
biz.yahoo.com - November 1 at 9:57 AM
Helius Medical Technologies to Receive ISO 13485 CertificateHelius Medical Technologies to Receive ISO 13485 Certificate
au.finance.yahoo.com - October 27 at 10:13 AM
HELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersHELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - September 21 at 9:41 AM
HELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other EventsHELIUS MEDICAL TECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
biz.yahoo.com - August 8 at 5:41 PM
Form 8-K/A HELIUS MEDICAL TECHNOLOG For: Jul 15Form 8-K/A HELIUS MEDICAL TECHNOLOG For: Jul 15
www.streetinsider.com - July 20 at 8:25 AM

SEC Filings

Helius Medical Technologies (OTCMKTS:HSDT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Helius Medical Technologies (OTCMKTS HSDT) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.